Home > Insider Trading > Filing (0001079973-22-000418)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1128189	Protokinetix Inc.	PKTX	Pharmaceutical Preparations (2834)	943355026

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1516077	Edward Clarence Smith	1409 Peachtree Road Daytona Beach FL 32114	President & Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-03-30	600,000	$0.05	31,594,443	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Acquisiton	2022-03-30	600,000	$0.00	600,000	$0.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
600,000	2022-03-30	2024-03-15	No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	13,235,160	Indirect	See footnote
Common Stock	1,850,000	Indirect	See footnote

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$0.06		2030-03-14	4,750,000	4,750,000	Direct
Common Stock	Stock Option	$0.11		2028-08-03	25,000,000	25,000,000	Direct
Common Stock	Stock Option	$0.11		2028-08-03	2,600,000	2,600,000	Direct
Common Stock	Warrant	$0.05	2022-03-18	2024-03-15	1,000,000	1,000,000	Direct
Common Stock	Warrant	$0.12	2019-12-19	2022-12-18	216,666	216,666	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2030-03-14	4,750,000	4,750,000	Direct
2028-08-03	25,000,000	25,000,000	Direct
2028-08-03	2,600,000	2,600,000	Direct
2024-03-15	1,000,000	1,000,000	Direct
2022-12-18	216,666	216,666	Direct

Footnotes

Shares purchased in a private placement from the Company.
Shares held by the Clarence E. Smith Trusts.
Shares held by Mr. Smith's retirement account.
Warrants purchased as part of a unit private placement from the Company.
Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan on March 15, 2022. On March 31, 2022, 1,187,500 shares vest; thereafter 1,187,500 shares vest each quarter.
Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan on August 4, 2021. Fully vested.
Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan on August 4, 2021. On September 30, 2021, 650,000 shares vest; thereafter 650,000 shares vest each quarter.